AVINDĒ is an accelerator that invests in scalable businesses, which aligns with the venture's goal of predicting drug resistance mutations. The venture's focus on AI and biotech also matches the accelerator's investment focus. However, the geography is not a perfect match, as the venture is prioritizing EU and the accelerator is based in the US.